Download presentation
Presentation is loading. Please wait.
Published byJoshua Boone Modified over 6 years ago
1
© The Author(s) 2015. Published by Science and Education Publishing.
Table 1. Selected open phase II/III trials in platinum resistant ovarian cancer Trial No Protocol Type NCT Avelumab with or with out Pegylated Liposomal doxorubicin Phase III NCT (COPAIL) Lurbinectedin Vs PLD or topotecan NCT Cediranib & olaparib Vs Chemotherapy Phase II/III NCT Niraparib (single arm) Phase II NCT Pembrolizumab with cisplatin & gemicitabine NCT AZD1775 with or without combination chemotherapy EORTC 55092 Pazopanib in combination with carboplatin/taxol S.G.D. Ganghadaran et al. Management of Platinum Resistant – Refractory Ovarian Cancer: A Short Review. Journal of Cancer Research and Treatment, 2016, Vol. 4, No. 2, doi: /jcrt-4-2-3 © The Author(s) Published by Science and Education Publishing.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.